ReviewBMJ oncology2024
Artificial intelligence across oncology specialties: current applications and emerging tools.
Review in BMJ oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Assessing clinical decision support system tools in precision oncology: piloting ring testing.ESMO real world data and digital oncology · 2026Article
- AI and human expertise in cancer care - striving for synergy.Nature reviews. Clinical oncology · 2026Article
- AI, digital twins, and healthcare utilization behaviour: evidence from a Swiss population survey.BMC health services research · 2025Article
- Article
- Exploring the Potential of Digital Twins in Cancer Treatment: A Narrative Review of Reviews.Journal of clinical medicine · 2025Review
- Applications of Artificial Intelligence in Acute Promyelocytic Leukemia: An Avenue of Opportunities? A Systematic Review.Journal of clinical medicine · 2025Review
- Patients' attitudes toward artificial intelligence (AI) in cancer care: A scoping review protocol.PloS one · 2025Article
- Long-term, automated stool monitoring using a novel smart toilet: A feasibility study.Neurogastroenterology and motility · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Oncology is becoming increasingly personalised through advancements in precision in diagnostics and therapeutics, with more and more data available on both ends to create individualised plans. The depth and breadth of data are outpacing our natural ability to interpret it. Artificial intelligence (AI) provides a solution to ingest and digest this data deluge to improve detection, prediction and skill development. In this review, we provide multidisciplinary perspectives on oncology applications touched by AI-imaging, pathology, patient triage, radiotherapy, genomics-driven therapy and surgery-and integration with existing tools-natural language processing, digital twins and clinical informatics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.